Literature DB >> 12387587

Butyrylcholinesterase activity and risk factors for coronary artery disease.

V M Alcântara1, E A Chautard-Freire-Maia, M Scartezini, M S J Cerci, K Braun-Prado, G Picheth.   

Abstract

The aim of this study was to verify which risk factors for coronary artery disease (CAD) are independently correlated with butyrylcholinesterase (BChE) activity. We studied 88 White individuals (43 males) aged 47.3+/-15.7 years (mean+/-SD; range: 14.0-80.0 years) including 38 with hyperlipidemia, 30 with hypertension and 5 with diabetes mellitus (DM). Simple correlation analysis showed that BChE activity was positively correlated with age, sex, body mass index, hypertension and DM, as well as with triglycerides (TGs), total cholesterol, low-density lipoprotein cholesterol and apolipoprotein B (Apo B). However, after a step-wise multiple regression analysis, the only risk factors for CAD that showed independent correlations with BChE activity were, in descending order of importance, Apo B, TGs and DM. Our findings seem to reinforce suggested associations of BChE activity with lipoprotein synthesis and with hypertension, as well as supporting previous data on the relation of BChE activity with disturbances found in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387587     DOI: 10.1080/00365510260296564

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  20 in total

1.  Mining OMIM for insight into complex diseases.

Authors:  Michael N Cantor; Yves A Lussier
Journal:  Stud Health Technol Inform       Date:  2004

2.  Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.

Authors:  G R Sridhar; G Nirmala; Allam Apparao; A S Madhavi; S Sreelatha; J Sudha Rani; P Vijayalakshmi
Journal:  Lipids Health Dis       Date:  2005-09-08       Impact factor: 3.876

3.  Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats.

Authors:  Felipe Schmitz; Emilene Barros da Silva Scherer; Maira Jaqueline da Cunha; Aline Andrea da Cunha; Daniela Delwing Lima; Débora Delwing; Carlos Alexandre Netto; Angela Terezinha de Souza Wyse
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

Review 4.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

5.  Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats.

Authors:  Bárbara Tagliari; Tiago M dos Santos; Aline A Cunha; Daniela D Lima; Débora Delwing; Angela Sitta; Carmem R Vargas; Carla Dalmaz; Angela T S Wyse
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

6.  High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis patients.

Authors:  Tanja Antunovic; Aleksandra Stefanovic; Marina Ratkovic; Branka Gledovic; Najdana Gligorovic-Barhanovic; Dragica Bozovic; Jasmina Ivanisevic; Milica Prostran; Marina Stojanov
Journal:  Int Urol Nephrol       Date:  2012-07-25       Impact factor: 2.370

7.  Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.

Authors:  Francieli M Stefanello; Renata Franzon; Bárbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

8.  Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Michael B Stout; Michael D Jensen; Stephen Brimijoin
Journal:  Endocrinology       Date:  2016-06-14       Impact factor: 4.736

Review 9.  Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease.

Authors:  Shani Shenhar-Tsarfaty; Shlomo Berliner; Natan M Bornstein; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2013-11-20       Impact factor: 3.444

10.  Mild hyperhomocysteinemia increases brain acetylcholinesterase and proinflammatory cytokine levels in different tissues.

Authors:  Emilene B S Scherer; Samanta O Loureiro; Fernanda C Vuaden; Aline A da Cunha; Felipe Schmitz; Janaína Kolling; Luiz Eduardo B Savio; Maurício R Bogo; Carla D Bonan; Carlos A Netto; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2014-03-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.